{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:42:44Z","timestamp":1765294964286,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.dsx.2018.04.039","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T22:47:32Z","timestamp":1524610052000},"page":"743-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Glycated hemoglobin targets and glycemic control: Link with lipid, uric acid and kidney profile"],"prefix":"10.1016","volume":"12","author":[{"given":"Anthony P.","family":"Sunjaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela F.","family":"Sunjaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.04.039_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2017\/2879249","article-title":"Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow-up clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: institutional-based cross-sectional study","volume":"2017","author":"Mariam","year":"2017","journal-title":"J Diabetes Res"},{"year":"2016","series-title":"Global report on diabetes","author":"World Health Organization","key":"10.1016\/j.dsx.2018.04.039_bib0010"},{"year":"2017","series-title":"Diabetes fact sheet. [Online]","author":"World Health Organization","key":"10.1016\/j.dsx.2018.04.039_bib0015"},{"year":"2013","series-title":"Riset kesehatan dasar","author":"Ministry of Health Indonesia","key":"10.1016\/j.dsx.2018.04.039_bib0020"},{"key":"10.1016\/j.dsx.2018.04.039_bib0025","first-page":"13","article-title":"Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study","author":"Ozder","year":"2014","journal-title":"Lipids Health Dis"},{"issue":"September (5)","key":"10.1016\/j.dsx.2018.04.039_bib0030","article-title":"Review the role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach","volume":"7","author":"Folli","year":"2011","journal-title":"Curr Diabetes Rev"},{"year":"2015","series-title":"Konsensus pengelolaan dan Pencegahan diabetes mellitus tipe 2 di Indonesia.","author":"Indonesian Society of Endocrinologists (PERKENI)","key":"10.1016\/j.dsx.2018.04.039_bib0035"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.dsx.2018.04.039_bib0040","article-title":"Glycemic target in standards of medical care in diabetes 2017","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"year":"2011","series-title":"Pedoman interpretasi data klinik","author":"Ministry of Health Indonesia","key":"10.1016\/j.dsx.2018.04.039_bib0045"},{"key":"10.1016\/j.dsx.2018.04.039_bib0050","first-page":"106","author":"National Cholesterol Education Program","year":"2002","journal-title":"Circulation"},{"issue":"February (5)","key":"10.1016\/j.dsx.2018.04.039_bib0055","article-title":"Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"year":"2016","series-title":"Diabetes Country profiles","author":"World Health Organization","key":"10.1016\/j.dsx.2018.04.039_bib0060"},{"issue":"February (2)","key":"10.1016\/j.dsx.2018.04.039_bib0065","article-title":"Barriers to achieving glycemic targets: who omits insulin and why?","volume":"33","author":"Weinger","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.dsx.2018.04.039_bib0070","article-title":"Factors associated with poor glycemic control among patients with type 2 diabetes","volume":"24","author":"Khattab","year":"2010","journal-title":"J Diabetes Its Compl"},{"issue":"3","key":"10.1016\/j.dsx.2018.04.039_bib0075","doi-asserted-by":"crossref","DOI":"10.4103\/0970-0218.183590","article-title":"Profiles and factors associated with poor glycemic control among inpatients with diabetes mellitus type 2 as a primary diagnosis in a teaching hospital","volume":"41","author":"Ismail","year":"2016","journal-title":"Indian J Commun Med"},{"issue":"October","key":"10.1016\/j.dsx.2018.04.039_bib0080","first-page":"6","article-title":"Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dares Salaam","author":"Kamuhabwa","year":"2014","journal-title":"Drug Healthc Patient Saf"},{"issue":"June (6)","key":"10.1016\/j.dsx.2018.04.039_bib0085","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.04.039_bib0090","doi-asserted-by":"crossref","unstructured":"Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. (2009) March; 5(3).","DOI":"10.1038\/ncpendmet1066"},{"issue":"4","key":"10.1016\/j.dsx.2018.04.039_bib0095","article-title":"A study on lipid profile levels of diabetics and non-diabetics among Naini region of Allahabad","volume":"33","author":"Smith","year":"2008","journal-title":"India Turk J Biochem"},{"issue":"December (12)","key":"10.1016\/j.dsx.2018.04.039_bib0100","article-title":"Lipoprotein lipase: structure, function, regulation and role in disease","volume":"80","author":"Mead","year":"2002","journal-title":"J Mol Med"},{"issue":"1","key":"10.1016\/j.dsx.2018.04.039_bib0105","article-title":"Association of younger age with poor glycemic and cholesterol control in asians with type 2 diabetes mellitus in Singapore","volume":"1","author":"Toh","year":"2011","journal-title":"J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.04.039_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2109542","article-title":"Factors associated with long-term control of type 2 diabetes mellitus","volume":"2016","author":"Badedi","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.dsx.2018.04.039_bib0115","first-page":"30","article-title":"Obesity and glycemic control in patients with diabetes mellitus: analysis of physician electronic health records in the US from 2009\u20132011","author":"Bae","year":"2016","journal-title":"J Diabetes Compl"},{"key":"10.1016\/j.dsx.2018.04.039_bib0120","first-page":"13","article-title":"Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study","author":"Ozder","year":"2014","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.dsx.2018.04.039_bib0125","article-title":"Correlation between glycemic control and lipid profile in type 2 diabetes patients: HbA1c as an indirect indicator of dyslipidemia","volume":"7","author":"Reddy","year":"2014","journal-title":"Asian J Pharma Clin Res"},{"issue":"October (4)","key":"10.1016\/j.dsx.2018.04.039_bib0130","article-title":"Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation","volume":"27","author":"Mullugeta","year":"2012","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"10.1016\/j.dsx.2018.04.039_bib0135","article-title":"Collateral benefits of improving glycemic control on lipids in a diabetic population","volume":"12","author":"Deichmann","year":"2012","journal-title":"Ochsner J"},{"issue":"3","key":"10.1016\/j.dsx.2018.04.039_bib0140","doi-asserted-by":"crossref","DOI":"10.13005\/bpj\/1040","article-title":"The correlation of uric acid levels with glycemic control in type II diabetic patients","volume":"9","author":"Babikr","year":"2016","journal-title":"Biomed Pharmacol J"},{"issue":"July (50)","key":"10.1016\/j.dsx.2018.04.039_bib0145","article-title":"Interactions between kidney disease and diabetes: dangerous liaisons","volume":"8","author":"Pecoits-Filho","year":"2016","journal-title":"Diabetol Metab Synd"},{"key":"10.1016\/j.dsx.2018.04.039_bib0150","first-page":"358","article-title":"Effects of intensive glucose lowering in type 2 diabetes","author":"The Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2018.04.039_bib0155","first-page":"358","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","author":"The ADVANCE Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.dsx.2018.04.039_bib0160","article-title":"Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function","volume":"35","author":"Zoppini","year":"2012","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2018.04.039_bib0165","doi-asserted-by":"crossref","DOI":"10.2337\/dc13-1102","article-title":"Association between glycemic control and morning blood pressure surge with vascular endothelial dysfunction in type 2 diabetic patients","volume":"37","author":"Yoda","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2018.04.039_bib0170","doi-asserted-by":"crossref","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthr Care Res"},{"issue":"August","key":"10.1016\/j.dsx.2018.04.039_bib0175","first-page":"19","article-title":"Hyperuricemia, type 2 diabetes mellitus, and hypertension: an emerging association","author":"Mortada","year":"2017","journal-title":"Curr Hypertens Rep"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118301474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118301474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:05:48Z","timestamp":1761728748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118301474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1871402118301474"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.04.039","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycated hemoglobin targets and glycemic control: Link with lipid, uric acid and kidney profile","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}